How Big is the Atrial Fibrillation Treatment Market?

The global atrial fibrillation treatment market size reached US$ 7.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.73% during 2023-2028.

What is Atrial Fibrillation Treatment?

Atrial fibrillation treatment represents medicines and surgeries used to treat patients suffering from irregular and rapid heart rates that enhance the risks of heart failure and stroke. They are of several types, such as maze surgery, catheter ablation, electric cardioversion, anticoagulants, anti-arrhythmics, etc. These categories of atrial fibrillation treatment effectively control heart rate, aid in restoring normal heart rhythm, and prevent cardiovascular complications. Consequently, they find extensive applications across numerous segments of the healthcare sector, including hospitals, cardiac labs, ambulatory surgical centers, etc.

Request PDF Sample of the Report: https://www.imarcgroup.com/atrial-fibrillation-treatment-market/req...

Atrial Fibrillation Treatment Market Trends/ Drivers:

The expanding geriatric population across the globe that is more prone to the risks of cardiovascular diseases (CVDs) is primarily driving the atrial fibrillation treatment market. Additionally, the shifting preferences toward minimally invasive (MI) surgical procedures are acting as significant growth-inducing factors. Besides this, the inflating investments undertaken by government bodies, especially in developing countries, to improve healthcare infrastructure and the escalating research and development (R&D) activities in the field of medical science are also positively influencing the market growth. Moreover, the launch of technologically advanced catheter ablation devices that can remove damaged heart tissues and the introduction of innovative mapping and recording systems are projected to fuel the atrial fibrillation treatment market over the forecasted period.

Competitive Landscape With Key Players:

• Abbott Laboratories
• Atricure Inc.
• Biotronik
• Boston Scientific Corporation
• Cardiofocus Inc.
• Hansen Medical Inc
• Auris Health
• Johnson & Johnson
• Siemens Healthineers
• Stereotaxis Inc., etc.

Key Market Segmentation

Breakup by Disorder Type:

• Paroxysmal Atrial Fibrillation
• Persistent Atrial Fibrillation
• Permanent Atrial Fibrillation
• Others

Breakup by Treatment Type:

• Medical Procedures
  • Surgical Procedures
    • Maze Surgery
    • Catheter Ablation
  • Non-Surgical Procedures
    • Electric Cardioversion
    • Diagnostic Catheters
    • Mapping and Recording Systems
    • Cardiac Monitors
    • Access Devices
    • Left Atrial Appendage and Closure Devices
    • Intracardiac Echocardiography (ICE) Systems
  • Medication
    • Anticoagulants
    • Anti-Arrhythmics

Breakup by End-User:

• Hospitals
• Cardiac Labs
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2140&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163